The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers
โ Scribed by Michael Meyer; Diana Beyer; Karin Vollhardt; Christiane Woischwill; Bernd Jilma; Gerhard Wolff
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 180 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.574
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg
The pharmacokinetics of prenalterol in healthy young volunteers after i.v. and oral dosing has been studied. There is evidence of non-linearity following the i.v. dosing. Evidence of dose-dependent pharmacokinetics following i.v. dosing has been obtained. The sustained-release formulation is very ef
The multiple-dose pharmacokinetics of the new HI-receptor antagonist, tazifylline, were investigated in healthy volunteers. From single-dose data, tazifylline appeared to be rapidly absorbed (median tm, of 0.6 h) and eliminated (t% 1.0 f 0.2 h). However, plasma levels measured on days 3 and 8 of the